- Home
- PRTS vs UNCY Comparison
PRTS vs UNCY Comparison
Compare PRTS & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- UNCY
- Stock Information
- Founded
- PRTS 1995
- UNCY 2016
- Country
- PRTS United States
- UNCY United States
- Employees
- PRTS N/A
- UNCY N/A
- Industry
- PRTS Auto & Home Supply Stores
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- UNCY Health Care
- Exchange
- PRTS Nasdaq
- UNCY Nasdaq
- Market Cap
- PRTS 48.0M
- UNCY 56.4M
- IPO Year
- PRTS 2007
- UNCY 2021
- Fundamental
- Price
- PRTS $0.74
- UNCY $4.08
- Analyst Decision
- PRTS Hold
- UNCY Strong Buy
- Analyst Count
- PRTS 1
- UNCY 4
- Target Price
- PRTS $0.70
- UNCY $63.75
- AVG Volume (30 Days)
- PRTS 636.3K
- UNCY 482.9K
- Earning Date
- PRTS 08-12-2025
- UNCY 08-14-2025
- Dividend Yield
- PRTS N/A
- UNCY N/A
- EPS Growth
- PRTS N/A
- UNCY N/A
- EPS
- PRTS N/A
- UNCY N/A
- Revenue
- PRTS $577,614,000.00
- UNCY N/A
- Revenue This Year
- PRTS $1.73
- UNCY N/A
- Revenue Next Year
- PRTS $5.48
- UNCY $1,178.98
- P/E Ratio
- PRTS N/A
- UNCY N/A
- Revenue Growth
- PRTS N/A
- UNCY N/A
- 52 Week Low
- PRTS $0.68
- UNCY $2.83
- 52 Week High
- PRTS $1.42
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- PRTS 45.40
- UNCY 39.43
- Support Level
- PRTS $0.73
- UNCY $3.86
- Resistance Level
- PRTS $0.94
- UNCY $4.97
- Average True Range (ATR)
- PRTS 0.06
- UNCY 0.30
- MACD
- PRTS -0.01
- UNCY 0.05
- Stochastic Oscillator
- PRTS 23.81
- UNCY 13.56
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.